Incidence and Burden of Lower-Risk Myelodysplastic Syndrome: A Nationwide Population Study
These findings highlight the substantial burden of transfusion dependency in LR-MDS patients, emphasizing the need for improved therapeutic strategies.
Authors
- Aurélie Schmidt
- M. Chartier (ORCID: https://orcid.org/0000-0003-2469-920X)
- François-Emery Cotté (ORCID: https://orcid.org/0000-0002-6758-4552)
- Arnaud Panes (ORCID: https://orcid.org/0000-0003-0021-9005)
- Thibault Comont (ORCID: https://orcid.org/0000-0002-6891-9238)
- Maud D’Aveni (ORCID: https://orcid.org/0000-0002-5909-2742)
- Nicolas Pagès (ORCID: https://orcid.org/0000-0003-0086-467X)
- J. Fernandes (ORCID: https://orcid.org/0000-0003-3881-4301)
- Léa Webert
Institutions
- Université Toulouse III - Paul Sabatier (FR)
- Bristol-Myers Squibb (France) (FR)
- Institut universitaire du cancer de Toulouse Oncopole (FR)
- Health Services and Performance Research Laboratory (FR)
- Centre Hospitalier de la Côte Basque (FR)
- Université de Lorraine (FR)
Publication Details
- Journal
- Clinical Lymphoma Myeloma & Leukemia
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.clml.2025.06.009
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00